Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF): An Internet-based Registry and Process of Care Improvement Program for Heart Failure Patients

NCT00344513 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00344513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00344513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF): An Internet-based Registry and Process of Care Improvement Program for Heart Failure Patients
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
December 16, 2002
Completion date
June 30, 2005
Enrollment
50,000
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, congestive